Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04116229 · ClinicalTrials.gov registry record · NA
Cognition and Magnetic Resonance Imaging of Brain Inflammation in Obesity
A NA study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT04116229 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 20 participants.
The verdict
NCT04116229, a NA study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The rate of obesity in the United States is high and is a risk factor for concurrent cognitive impairment and, in late life, dementias such as Alzheimer's disease. In order to prevent or reduce cognitive impairment, the mechanism underlying the link between obesity and cognitive impairment must be understood. The current study aims to provide preliminary data on whether brain inflammation occurs in obesity and relates to cognitive deficits using magnetic resonance neuroimaging and cognitive testing. It is hypothesized that obese individuals will have greater brain inflammation and lower cognitive function compared to normal-weight individuals. Further, it is predicted that brain inflammation will relate to cognitive function and plasma indicators of inflammation in obese individuals.
Interventions
- BEHAVIORAL Cognitive testing
- PROCEDURE Magnetic resonance imaging
- PROCEDURE Oral glucose tolerance test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-03-19 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04116229
The ClinicalTrials.gov registry entry for NCT04116229 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cognitive testing is the first listed.
NCT04116229 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04116229 about?
NCT04116229 is a clinical study titled "Cognition and Magnetic Resonance Imaging of Brain Inflammation in Obesity". The rate of obesity in the United States is high and is a risk factor for concurrent cognitive impairment and, in late life, dementias such as Alzheimer's disease. In order to prevent or reduce cognitive impairment, the mechanism underlying the link between obesity and cognitive impairment must be u...
What is the current status of trial NCT04116229?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2019-03-19. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT04116229?
The interventions under investigation include: Cognitive testing (BEHAVIORAL), Magnetic resonance imaging (PROCEDURE), Oral glucose tolerance test (PROCEDURE).
Who is sponsoring clinical trial NCT04116229?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.